Quarterly Result30 Apr 2026, 10:11 pm
Godrej Agrovet FY26 Revenue up 9% to ₹10,233 Cr, PBT up 17%
AI Summary
Godrej Agrovet Limited announced its financial results for Q4 and the full year ended March 31, 2026. For FY26, consolidated revenue from operations grew 9% year-on-year to ₹10,233 crore, while Profit Before Tax (excluding non-recurring & exceptional items) increased by a robust 17% to ₹569 crore. In Q4 FY26, consolidated revenue was ₹2,333 crore, and PBT was ₹87 crore. The company's CEO highlighted strong performance in Oil Palm and Animal Nutrition businesses, with Astec LifeSciences achieving EBITDA break-even. Poultry & Processed Foods saw improved profitability from branded products, while Dairy and Crop Care faced headwinds. GAVL also strengthened its sustainability agenda, retaining a CDP Leadership "A–" rating.
Key Highlights
- FY26 consolidated revenue grew 9% YoY to ₹10,233 crore.
- FY26 PBT (excl. non-recurring) increased 17% YoY to ₹569 crore.
- Oil Palm and Animal Nutrition businesses delivered exceptional performance.
- Astec LifeSciences achieved EBITDA break-even, significantly reducing losses.
- Company maintained CDP Leadership "A–" rating for sustainability efforts.